Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

App aims to keep HIV patients with addiction on track

NCT ID NCT06109571

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study tests a mobile app called Connections for people living with HIV who also have substance use disorders. The app provides resources, weekly check-ins, discussion rooms, and private messaging with peer mentors and care teams. Researchers want to see if using the app helps patients keep the virus suppressed and attend clinic appointments. About 433 participants from 8 clinics will use the app for one year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Connections mobile app (mHealth intervention with peer support and clinic resources)
What this could lead to
If successful, this app could become a low-cost tool to help people with HIV and substance use disorders stay engaged in care and keep the virus under control.
What could go wrong
This is an implementation study, not a test of a new drug. The app may not work for everyone, and results depend on how well clinics and patients adopt it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

433 people

The number who actually took part.

Started

Dec 2023

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Able to read, write and speak English * Receives HIV Disease Care at Vivent Health * At risk for poor engagement in HIV care, as evidenced by any one of the following: * Prior missed clinic visits * Poor adherence to medical treatment defined as 2 or more missed doses of medication in a month * Unhealthy alcohol or other substance use, as evidenced by a diagnosis of substance use disorder on the patient's problem list, a prior referral to alcohol or substance abuse services, or answering "yes" to one or both of the following screening questions: * Has drinking alcohol or using drugs (including marijuana) ever caused problems in your life, such as damaging relationships, causing you to not meet obligations at work, or getting in trouble with the law? * Are you currently participating in any treatment or counseling because of problems caused by drug use? This can include groups like N. A., or one-on-one interaction with a doctor or therapist. Exclusion Criteria: * Individuals who do not currently have a smartphone or are unwilling to obtain a smartphone will not be able to participate in this study. * People who are unwilling to download and activate the Connections app. * People with cognitive or other impairment that precludes the capacity to consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV infections are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Vivent Health Clinic

    Denver, Colorado, 80246, United States

  • Vivent Health Clinic

    Kansas City, Missouri, 64130, United States

  • Vivent Health Clinic

    St Louis, Missouri, 63103, United States

  • Vivent Health Clinic

    Austin, Texas, 78752, United States

  • Vivent Health Clinic

    Green Bay, Wisconsin, 54301, United States

  • Vivent Health Clinic

    Kenosha, Wisconsin, 53140, United States

  • Vivent Health Clinic

    Madison, Wisconsin, 53703, United States

  • Vivent Health Clinic

    Milwaukee, Wisconsin, 53212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.